Kosmac, K., Bantug, G. R., Pernjak Pugel, E., Cekinović, Đ., Jonjić, S. & Britt, W. J. (2013). Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development. PLoS Pathogens, 9. (3). doi: 10.1371/journal.ppat.1003200
Kosmac, Kate, et al. "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development." PLoS Pathogens, vol. 9, no. 3, 2013. https://doi.org/10.1371/journal.ppat.1003200
Kosmac, Kate, Glenn Robert Bantug, Ester Pernjak Pugel, Đurđica Cekinović, Stipan Jonjić and William J. Britt. "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development." PLoS Pathogens 9, no. 3 (2013). https://doi.org/10.1371/journal.ppat.1003200
Kosmac, K., et al. (2013) 'Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development', PLoS Pathogens, 9(3). doi: 10.1371/journal.ppat.1003200
Kosmac K, Bantug GR, Pernjak Pugel E, Cekinović Đ, Jonjić S, Britt WJ. Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development. PLoS Pathogens [Internet]. 2013 March 07 [cited 2024 July 05];9(3). doi: 10.1371/journal.ppat.1003200
K. Kosmac, G. R. Bantug, E. Pernjak Pugel, Đ. Cekinović, S. Jonjić and W. J. Britt, "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development", PLoS Pathogens, vol. 9, no. 3, March 2013. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:792777. [Accessed: 05 July 2024]